PPARδ agonist raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-12-06 and is reviewed periodically as new material appears.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516; GW-1516; endurobol | GW501516 is the research code |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator |
| Molecular formula | C21H18F3NO3S2 | Established chemical formula |
| Molar mass | 453.5 g/mol | Calculated from the formula |
| Regulatory status | Prohibited in sport; not approved as medicine | Status varies by country |
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Research has been ongoing since the 1960s to determine the proportion of 14C in the atmosphere over the past 50,000 years. The resulting data, in the form of a calibration curve, is now used to convert a given measurement of radiocarbon in a sample into an estimate of the sample's calendar age. Other corrections must be made to account for the proportion of 14C in different types of organisms (fractionation), and the varying levels of 14C throughout the biosphere (reservoir effects). Additional complications come from the burning of fossil fuels, such as coal and oil, and from the above-ground nuclear tests done in the 1950s and 1960s. Because the time it takes to convert biological materials to fossil fuels is substantially longer than the time it takes for their 14C to decay below detectable levels, fossil fuels contain almost no 14C. As a result, beginning in the late 19th century, there was a noticeable drop in the proportion of 14C as the carbon dioxide generated from burning fossil fuels began to accumulate in the atmosphere. Conversely, nuclear testing increased the amount of 14C in the atmosphere, which reached a maximum in about 1965 of almost double the amount present in the atmosphere prior to nuclear testing. Measurement of radiocarbon was originally done by beta-counting devices, which counted the amount of beta radiation emitted by decaying 14C atoms in a sample.
An artificial metalloenzyme (ArM) is a designer metalloprotein, not found in nature, which can catalyze desired chemical reactions. Despite fitting into classical enzyme categories, ArMs also have potential in new-to-nature chemical reactivity like catalysing Suzuki coupling, metathesis etc., which were never reported among natural enzymatic reactions. ArMs have two main components: a protein scaffold and an artificial catalytic moiety, which, in this case, features a metal center. This class of designer biocatalysts is unique because of the potential to improve the catalytic performance through chemogenetic optimization, a parallel improvement of both the direct metal surrounding (first coordination sphere) and the protein scaffold (second coordination sphere).The second coordination sphere (protein scaffold) is easily evolvable and, in the case of ArMs, responsible for very high (stereo)selectivity. With the progress in organometallic synthesis and protein engineering, more and more new kind of design of ArMs were developed, showing promising future in both academia and industrial aspects. In 2018, one-half of the Nobel Prize in Chemistry was awarded to Frances H. Arnold "for the directed evolution of enzymes", who elegantly evolved artificial metalloenzymes to realize efficient and highly selective new-to-nature chemical reactions in vitro and in vivo.
=== Ecuador's expulsion of Cuban ambassador === On 4 March 2026, Ecuador expelled Cuban Ambassador Basilio Gutierrez and his staff, declaring them persona non grata. No reason was provided for the expulsion.
Numerous protesters asked for a civilian government. On Saturday 13 April 2019, al-Burhan announced that a civilian government would soon be established. Al-Burhan promised that the transitional period would take a maximum of two years. Negotiations started to take place with the opposition leaders to achieve this.
Sources: en.wikipedia.org
Beta-peptides (β-peptides) are peptides derived from β-amino acids, in which the amino group is attached to the β-carbon (i.e. the carbon two atoms away from the carboxylate group). The parent β-amino acid is β-alanine (H2NCH2CH2CO2H), a common natural substance, but most examples feature substituents in place of one or more C-H bonds. β-peptides usually do not occur in nature. β-Peptide-based antibiotics are being explored as ways of evading antibiotic resistance. Early studies in this field were published in 1996 by the group of Dieter Seebach and that of Samuel Gellman.
It is the heaviest doubly magic nuclide known. The four primordial isotopes of lead are all observationally stable, meaning that they are predicted to undergo radioactive decay but no decay has been observed yet. These four isotopes are predicted to undergo alpha decay and become isotopes of mercury which are themselves radioactive or observationally stable. There are trace quantities existing of the radioactive isotopes 209–214. The largest and most important is lead-210 as it has by far the longest half-life (22.2 years) and occurs in the abundant uranium decay series. Lead-211, -212, and -214 are present in the decay chains of uranium-235, thorium-232, and uranium-238, further, making these three lead isotopes also detectable in natural sources. The more minute traces of lead-209 arise from three rare decay branches: the beta-delayed-neutron decay of thallium-210 (in the uranium series), the last step of the neptunium series, traces of which are produced by neutron capture in uranium ores, and the very rare cluster decay of radium-223 (yielding also carbon-14). Lead-213 also occurs in a minor branch of the neptunium series. Lead-210 is particularly useful for helping to identify the ages of samples by measuring its ratio to lead-206 (both isotopes are present in a single decay chain). In total, 43 lead isotopes have been synthesized, from 178Pb to 220Pb.
==== United Kingdom ==== Insulin, and all other medications, are supplied free of charge to people who use it to manage their diabetes by the National Health Services of the countries of the United Kingdom.
Sources: en.wikipedia.org
Economic failings in the Communist system were becoming more obvious across eastern Europe during the 1980s, as for instance, the yearly per capita GDP of East Germans was barely half that of those in West Germany. Infrastructure investments were also deficient in countries like Poland, Hungary, and Czechoslovakia, while at the same time, eastern bloc countries were losing their share of world trade. Meanwhile, countries throughout western Europe continued to prosper. By the mid-1980s, historian John W. Young observes, this contrast had become stark and rather than an integrated economic community at the technological frontier, Eastern Europe remained heavily indebted, inefficient, and unable to compete in world markets—a burden the Soviet economy itself had to help sustain through subsidized oil and raw materials. In 1985, Reagan and Gorbachev held their first of four "summit" meetings, beginning in Geneva, Switzerland. After discussing policy, facts, etc., Reagan invited Gorbachev to go with him to a small house near the beach. The two leaders spoke in that house well over their time limit, but came out with the news that they had planned two more (soon three more) summits. The second summit took place the following year, in 1986 on October 11, in Reykjavík, Iceland. The meeting was held to pursue discussions about scaling back their intermediate-range ballistic missile arsenals in Europe.
=== Differentiation === Hemp juice can be clearly distinguished from other liquid products of the hemp plant. Hemp milk and hemp oil, just like soy milk, are produced from the seeds of the plant. Beverages such as hemp beer use the dried flowers or dried leaves of the plant. When dried parts of hemp are used in water and extract results. Water extraction only contains a proportion of about 10% of hemp ingredients otherwise found in cold-pressed juice, therefore, cold-pressed hemp juice contains a much higher percentage of notable ingredients. More importantly, water extraction does not contain any of the important cannabinoids as they cling to the fatty acids of the plant, which are not dissolved in water extraction. That being said, cold-pressed hemp juice does contain the valuable cannabinoids. These valuable ingredients are also preserved when hemp is juiced in a conventional home blender. This process of juicing is not suitable for industrial hemp because the plant fibers used for industrial applications are too hard to digest for humans.
=== EC 2.6.99: Transferring Other Nitrogenous Groups === EC 2.6.99.1: dATP(dGTP)—DNA purinetransferase EC 2.6.99.2: pyridoxine 5′-phosphate synthase EC 2.6.99.3: O-ureido-L-serine synthase EC 2.6.99.4: Now EC 2.3.1.234, N6-L-threonylcarbamoyladenine synthase.
The Hong Kong Rugby Football Union was founded in 1953. Rugby is long established, partly as a result of its being a British colony. Hong Kong Sevens is held annually in Hong Kong and is considered the premier tournament on the World Rugby Sevens Series competition. Hong Kong national rugby union team is ranked 23rd in the world with a peak rating of 21st (2018–2022). Hong Kong is one of the best teams in Asia and has finished first place in the Asia Rugby Championship in 2018, 2019, 2022, 2023, 2024, and 2025. They qualified for the 2027 Rugby World Cup for the first time by winning the 2025 Asia Rugby Championship. The Hong Kong national rugby sevens team is widely regarded as the best rugby sevens team in Asia and a regular participant in the Rugby World Cup Sevens. Hong Kong has won the Asian Sevens Series a record 8 times and the Asian Games 2 times.
Sources: en.wikipedia.org
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.
No. It has no approved medical indication in any country. Regulatory agencies have not cleared it for treatment or prevention of any condition.
Early clinical work stopped after rodent carcinogenicity findings. Those animal results raised concerns about long-term human risk, although direct human evidence is lacking. The human relevance of the tumors remains an open scientific question.
No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.